Profusa, Inc. Files 8-K on New Agreements and Debt
Ticker: PFSA · Form: 8-K · Filed: 2026-04-06T06:06:18-04:00
Sentiment: neutral
Topics: debt-financing, equity-sale, material-agreement
TL;DR
Profusa just dropped an 8-K: new debt and equity deals signed April 2nd. Watch this space.
AI Summary
Profusa, Inc. filed an 8-K on April 6, 2026, detailing a material definitive agreement and the creation of a direct financial obligation. This includes an amendment to a Securities Purchase Agreement dated April 2, 2026, and a Senior Secured Convertible Promissory Note issued to ASCEN on April 2, 2026. The filing also notes unregistered sales of equity securities and other events.
Why It Matters
This filing indicates Profusa, Inc. has entered into new financing agreements, which could impact its financial obligations and equity structure.
Risk Assessment
Risk Level: medium — The filing involves new financial obligations and unregistered equity sales, which can introduce financial and regulatory risks.
Key Players & Entities
- Profusa, Inc. (company) — Filer
- ASCEN (company) — Note Holder
- April 2, 2026 (date) — Date of Securities Purchase Agreement Amendment and Promissory Note
- April 6, 2026 (date) — Filing Date of 8-K
FAQ
What is the principal amount of the Senior Secured Convertible Promissory Note issued to ASCEN?
The filing does not explicitly state the principal amount of the Senior Secured Convertible Promissory Note in the provided text.
What are the key terms of the amended Securities Purchase Agreement dated April 2, 2026?
The provided text mentions an amendment to the Securities Purchase Agreement but does not detail its specific terms.
What was the nature of the unregistered sales of equity securities mentioned in Item 3.02?
The filing indicates unregistered sales of equity securities occurred but does not provide details on the number of shares or the price in the provided text.
What is the purpose of the non-binding letter of intent dated March 31, 2026?
The filing lists a non-binding letter of intent but does not specify its purpose or the parties involved in the provided text.
What specific 'Other Events' are being reported under Item 8.01?
The filing indicates 'Other Events' are being reported under Item 8.01, but the specific nature of these events is not detailed in the provided text.
From the Filing
EDGAR Filing Documents for 0001213900-26-040111 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0001213900-26-040111 Filing Date 2026-04-06 Accepted 2026-04-06 06:06:18 Documents 17 Period of Report 2026-04-02 Items Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 3.02: Unregistered Sales of Equity Securities Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits Interactive Data Document Format Files Seq Description Document Type Size 1 CURRENT REPORT ea0285151-8k_profusa.htm iXBRL 8-K 46707 2 AMENDMENT NO. 4, DATED AS OF APRIL 2, 2026, TO THE SECURITIES PURCHASE AGREEMENT ea028515101ex10-1.htm EX-10.1 457387 3 SENIOR SECURED CONVERTIBLE PROMISSORY NOTE, DATED APRIL 2, 2026, ISSUED TO ASCEN ea028515101ex10-2.htm EX-10.2 184091 4 NON-BINDING LETTER OF INTENT, DATED MARCH 31, 2026 (AS AMENDED AND RESTATED ON A ea028515101ex99-1.htm EX-99.1 42554 5 PRESS RELEASE ea028515101ex99-2.htm EX-99.2 17543 6 GRAPHIC ea028515101ex10-1img1.jpg GRAPHIC 4937 7 GRAPHIC ea028515101ex10-1img2.jpg GRAPHIC 2215 Complete submission text file 0001213900-26-040111.txt 1107547 Data Files Seq Description Document Type Size 8 XBRL SCHEMA FILE nvacw-20260402.xsd EX-101.SCH 3023 9 XBRL LABEL FILE nvacw-20260402_lab.xml EX-101.LAB 34239 10 XBRL PRESENTATION FILE nvacw-20260402_pre.xml EX-101.PRE 22363 20 EXTRACTED XBRL INSTANCE DOCUMENT ea0285151-8k_profusa_htm.xml XML 3313 Mailing Address 207 WEST 25TH ST, 9TH FLOOR NEW YORK NY 10001 Business Address 207 WEST 25TH ST, 9TH FLOOR NEW YORK NY 10001 212-494-9022 Profusa, Inc. (Filer) CIK : 0001859807 (see all company filings) EIN. : 863437271 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-41177 | Film No.: 26839493 SIC : 3841 Surgical & Medical Instruments & Apparatus (CF Office: 08 Industrial Applications and Services)